Craig OkadaM.D.

  • Associate Professor of Medicine, School of Medicine

Expertise

  • Cancer

Special focus on

  • Cutaneous T-cell Lymphoma (CTCL)
  • Lymphoma

Insurance

Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.

Biography

Dr. Okada specializes in the care of patients with lymphoma. He joined OHSU in 2004 and has a particular interest the treatment of cutaneous lymphoma and immunotherapy. With over 30 different types of lymphoma, focusing his practice in lymphoma allows Dr. Okada to appreciate the subtle difference between the various kinds of lymphoma. This kind of expertise helps in choosing the best treatment for each patient. 

Dr. Okada is part of the OHSU multidisciplinary lymphoma group, which allows for coordinated care from radiation oncology, oncology and bone marrow transplant. He conducts several clinical trials in lymphoma, making promising new treat available for patients with this disease.

Education

  • Ph.D., 1990, Stanford University
  • M.D., 1990, Stanford University
  • Residency:

    • Stanford University, 1992
  • Fellowship:

    • Hematology, Stanford University, 1993
  • Certifications:

    • American Board of Internal Medicine (hematology), 1996 (recertified 2007)

Languages

  • English

Memberships and associations

  • American Society of Hematology

Patient ratings

4.9 out of 5 (338 Ratings, 156 Comments)

The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys.

  1. {{ item.comments[0]['comment'] }}